Balchem Q2 2025: record net sales $255.5M, adj. EPS $1.27 beat

BALCHEM CORP

2025-Q2 EPS reported $2.30 revenue$505,986,000

Net sales $255.5M, +9.1% YoY; GAAP EPS $1.17 vs $0.98 prior year quarter.
Record adjusted EBITDA $69.2M (+11.2%); adjusted EPS $1.27 vs $1.09.
All three segments grew; record sales and earnings in Human Nutrition & Health and Specialty Products.
Plans new $36M micro-encapsulation facility in Orange County, NY, pending county approval.
EU imposes provisional anti-dumping duties of 95.4%-120.8% on Chinese choline chloride imports effective July 1, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.